These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1706860

  • 1. [Effectiveness of intravenous immunoglobulins in polymyositis and dermatomyositis. An open trial in 15 patients].
    Cherin P, Herson S, Wechsler B, Piette JC, Bletry O, Degennes C, Ziza JM, Du LT, Godeau P.
    Presse Med; 1991 Feb 16; 20(6):244-9. PubMed ID: 1706860
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.
    Cherin P, Herson S, Wechsler B, Piette JC, Bletry O, Coutellier A, Ziza JM, Godeau P.
    Am J Med; 1991 Aug 16; 91(2):162-8. PubMed ID: 1714235
    [Abstract] [Full Text] [Related]

  • 3. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P, Piette JC, Wechsler B, Bletry O, Ziza JM, Laraki R, Godeau P, Herson S.
    J Rheumatol; 1994 Jun 16; 21(6):1092-7. PubMed ID: 7932419
    [Abstract] [Full Text] [Related]

  • 4. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
    Chérin P, Herson S.
    Ann Med Interne (Paris); 1993 Jun 16; 144(8):521-5. PubMed ID: 8179241
    [Abstract] [Full Text] [Related]

  • 5. Therapy of polymyositis and dermatomyositis.
    Marie I, Mouthon L.
    Autoimmun Rev; 2011 Nov 16; 11(1):6-13. PubMed ID: 21740984
    [Abstract] [Full Text] [Related]

  • 6. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P.
    Ann Med Interne (Paris); 2000 May 16; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [Abstract] [Full Text] [Related]

  • 7. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.
    Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S.
    Arthritis Rheum; 2002 Feb 16; 46(2):467-74. PubMed ID: 11840450
    [Abstract] [Full Text] [Related]

  • 8. [Current therapy for polymyositis and dermatomyositis].
    Chérin P.
    Rev Med Interne; 2008 Jun 16; 29 Spec No 2():9-14. PubMed ID: 18927983
    [Abstract] [Full Text] [Related]

  • 9. Polymyositis/dermatomyositis: clinical features and outcome in 22 patients.
    Baron M, Small P.
    J Rheumatol; 1985 Apr 16; 12(2):283-6. PubMed ID: 3875720
    [Abstract] [Full Text] [Related]

  • 10. Recovering autonomy is a key advantage of home-based immunoglobulin therapy in patients with myositis: A qualitative research study.
    Chérin P, Pindi Sala T, Clerson P, Dokhan A, Fardini Y, Duracinsky M, Crave JC, Chassany O.
    Medicine (Baltimore); 2020 Feb 16; 99(7):e19012. PubMed ID: 32049796
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
    Pongratz D.
    J Neurol; 2006 Sep 16; 253 Suppl 5():V64-5. PubMed ID: 16998756
    [Abstract] [Full Text] [Related]

  • 12. Management of polymyositis and dermatomyositis.
    Ansell BM.
    Clin Rheum Dis; 1984 Apr 16; 10(1):205-13. PubMed ID: 6734117
    [Abstract] [Full Text] [Related]

  • 13. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.
    Unger L, Kampf S, Lüthke K, Aringer M.
    Rheumatology (Oxford); 2014 Sep 16; 53(9):1630-8. PubMed ID: 24706995
    [Abstract] [Full Text] [Related]

  • 14. Dermatomyositis-polymyositis in children.
    Goel KM, King M.
    Scott Med J; 1986 Jan 16; 31(1):15-9. PubMed ID: 3515551
    [Abstract] [Full Text] [Related]

  • 15. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I, Menard JF, Hatron PY, Hachulla E, Mouthon L, Tiev K, Ducrotte P, Cherin P.
    Arthritis Care Res (Hoboken); 2010 Dec 16; 62(12):1748-55. PubMed ID: 20722047
    [Abstract] [Full Text] [Related]

  • 16. [Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
    Stoll T, Michel BA, Neidhart M, Wassmer P, Neidl K, Fehr K, Wagenhäuser FJ.
    Schweiz Med Wochenschr; 1992 Sep 26; 122(39):1458-65. PubMed ID: 1411405
    [Abstract] [Full Text] [Related]

  • 17. Treatment of polymyositis and dermatomyositis.
    Kaye SA, Isenberg DA.
    Br J Hosp Med; 1992 Sep 26; 52(9):463-8. PubMed ID: 7874361
    [Abstract] [Full Text] [Related]

  • 18. Therapy of polymyositis and dermatomyositis.
    Marie I.
    Presse Med; 2011 Apr 26; 40(4 Pt 2):e257-70. PubMed ID: 21334847
    [Abstract] [Full Text] [Related]

  • 19. Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment.
    Ramírez G, Asherson RA, Khamashta MA, Cervera R, D'Cruz D, Hughes GR.
    Semin Arthritis Rheum; 1990 Oct 26; 20(2):114-20. PubMed ID: 2251506
    [Abstract] [Full Text] [Related]

  • 20. [Intravenous immunoglobulins in polymyositis and dermatomyositis].
    Chérin P, Herson S.
    Rev Med Interne; 1999 Oct 26; 20 Suppl 4():436s-439s. PubMed ID: 10522319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.